Skip to main content
  1. aggrego News
  2. Chronic ITP

Non-O Blood Type May Increase VTE Risk in Patients With Cancer

Recommended
Study Finds Racial Disparities in Cancer-Associated Thrombosis
Non-O Blood Type May Increase VTE Risk in Patients With Cancer
Early Treatment of Rituximab Combined With Eltrombopag for Secondary Thrombocytopenic Purpura in Rheumatoid Arthritis
cITP Associated With Familial Autoimmune Dysregulation
SDF-1α Facilitates Mesenchymal Stem Cells to Induce Regulatory B Cell Differentiation from Patients With Immune Thrombocytopenia
Quantitative LC–MS/MS Uncovers the Regulatory Role of Autophagy in Immune Thrombocytopenia
Unexpected Thrombocytosis Could Flag Occult Cancer
Effectiveness of Corticosteroids in the Treatment of Chemotherapy-Induced Thrombocytopenia

Non-O Blood Type May Increase VTE Risk in Patients With Cancer

header-info
Apr, 27, 2022
social-elements
New findings suggest that patients with cancer who have non-O blood types (types A, B, and AB) have a higher risk of developing VTEs at 3 months or more after their initial cancer diagnosis. 

Footer branding


Footer main navigation

  • About Us
  • Contact Us
  • Privacy Policy
  • Sign in

HMP Global Products

  • HMP Global Learning Network
  • Consultant360
  • VRTX

Copyright branding

© 2022 HMP Global. Aggrego is a trademark of HMP Global. All Rights Reserved.

<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->

Home

Site branding - mobile

Upper navigation

  • Today
    Today
  • Following
    Following
  • Specialties
    Specialties

Main navigation

  • News
    news
  • TV
    TV
  • Radio
    Radio
  • Conference Hub
    Conf hub

Partners links

  • Advances
    Advances Menu

User imageSign in

Register

Additional navigation- 1

  • Acute Basal Cell Carcinoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • AML+CLL
  • Breast Cancer
  • CAR-T Cell Therapy
  • Chronic ITP
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous Squamous-Cell Carcinoma
  • Diffuse Large B-Cell Lymphoma
  • Early Breast Cancer
  • FDA Approvals
  • Febrile Neutropenia
  • Follicular Lymphoma
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Graft Versus Host Disease
  • Gynecologic Cancer
  • Head And Neck Cancer
  • Healthcare Policy
  • Hematologic Malignancies
  • HER2 Low mBC
  • Immuno Oncology

Additional navigation- 2

  • Liver Cancer
  • Lung Cancer
  • Marginal Zone Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Non-Small-Cell Lung Cancer
  • Oncology Nursing
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pediatric Oncology
  • Prostate Cancer
  • Radiation Oncology
  • Renal Cell Carcinoma
  • RET+ Advanced Thyroid Cancer
  • RET+ NSCLC
  • Sarcoma
  • Skin Cancer
  • Solid Tumors
  • Supportive Care
  • Surgical Cancer
  • Urethral Carcinoma

Advances menu

  • KEYNOTE-522 Trial
  • Pancreatic Cancer Action Network: Precision Promise Trial